[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2



[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2

A1AA1V2VV2X3XX3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9Q10QQ10X11XX11A12AA12K13KK13W14WW14L15LL15N16NN16S17SS17M18MM18R19RR19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34

SMILES None
InChIKey None
Sequence AVXEIQLMHQXAKWLNSMRRVEWLRKKLQDVHNF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2

A1AA1V2VV2X3XX3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9Q10QQ10X11XX11A12AA12K13KK13W14WW14L15LL15N16NN16S17SS17M18MM18R19RR19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.